Besides, in our novel research attempt, we extended the study objective to utilize the MRI‐derived amyloid and tau pathology signatures as proxies for AD detection and risk prediction while also comprehensively examining regional attribution distribution patterns—an aspect often overlooked in machine learning‐based AD research. The gene discussed is MAPT; the disease is Alzheimer disease.